“Wish however, we would finally learn what this company was.
1. A new technology to test blood or
2. An engineering company taking existing blood testing knowledge and miniaturizing it.
Since the impact of this trial is the future of the “fake it till you make it” mindset this difference...”Read full review »
Eagleye Steve via Apple Podcasts ·
United States of America ·
08/31/21
“Anyone who rates this less than 5 doesn’t get it. Outstanding research, fact-checking and storytelling. Investors win when journalists like Carryou tell it like it is. Freedom of the press at its finest.”
googleisnogood via Apple Podcasts ·
United States of America ·
09/05/21